RDI Partners

RDI Partners is an Australian professional services firm focused on R&D Tax Incentive advisory and related corporate services rather than drug discovery or therapeutic development. The company helps Australian technology developers and foreign-owned groups establish an Australian presence and navigate eligibility, documentation, compliance, and financial structuring for the Australian R&D Tax Incentive regime. Its services appear particularly relevant to biotech and healthcare companies running early-stage development programs in Australia, including support tied to clinical-development spend and governance requirements. Recent public disclosures show RDI Partners supporting Onco-Innovations' Australian Phase I strategy, but RDI Partners itself is not a biotech or pharma developer.